Next Article in Journal
The Clinical Significance of Unknown Sequence Variants in BRCA Genes
Next Article in Special Issue
DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes
Previous Article in Journal
Werner et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
Article Menu

Export Article

Expression of Concern published on 7 April 2016, see Cancers 2016, 8(4), 44.

Open AccessReview
Cancers 2010, 2(3), 1683-1688; doi:10.3390/cancers2031683

Epigenetic Therapy in Human Choriocarcinoma

Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan
Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, Japan
Author to whom correspondence should be addressed.
Received: 18 August 2010 / Revised: 3 September 2010 / Accepted: 9 September 2010 / Published: 10 September 2010
(This article belongs to the Special Issue Epigenetics of Cancer Progression)
View Full-Text   |   Download PDF [114 KB, uploaded 10 September 2010]


Because epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and promotion of tumorigenesis in choriocarcinomas, novel compounds endowed with a histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. HDAC inhibitors (HDACIs) were able to mediate inhibition of cell growth, cell cycle arrest, apoptosis, and the expression of genes related to the malignant phenotype in choriocarcinoma cell lines. In this review, we discuss the biologic and therapeutic effects of HDACIs in treating choriocarcinoma, with a special focus on preclinical studies.
Keywords: choriocarcinoma; epigenetics; histone deacetylase inhibitors choriocarcinoma; epigenetics; histone deacetylase inhibitors
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Takai, N.; Narahara, H. Epigenetic Therapy in Human Choriocarcinoma. Cancers 2010, 2, 1683-1688.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top